Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
The need to embrace molecular profiling of tumor cells in prostate and bladder cancerBrian J Duggan, John J McKnight, Kate E Williamson, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|April 13, 2007
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potentialRodolfo Montironi, Marina Scarpelli, Antonio Lopez-Beltran, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 19, 2017
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancerPeter Bankhead, José A Fernández, Darragh G McArt, et al.
Cell Death Discovery|September 15, 2017
IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancerRyan A Hutchinson, Helen G Coleman, Kathy Gately, et al.
Histopathology|March 26, 2018
Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysisMaurice B Loughrey, Peter Bankhead, Helen G Coleman, et al.
Scientific Reports|December 6, 2017
QuPath: Open source software for digital pathology image analysisPeter Bankhead, Maurice B Loughrey, José A Fernández, et al.
Histopathology|March 12, 2014
The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancerDavid P Boyle, Darragh G McArt, Gareth Irwin, et al.
Oncotarget|August 29, 2015
Automated tumor analysis for molecular profiling in lung cancerPeter W Hamilton, Yinhai Wang, Clinton Boyd, et al.
The Journal of Pathology|June 28, 2011
PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancerIan Paul, Kienan I Savage, Jaine K Blayney, et al.
British Journal of Cancer|May 20, 2017
Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort studyRonan T Gray, Maurice B Loughrey, Peter Bankhead, et al.
Pageof 5